Home    eJManager.com Add Your Journal   |    Follow on Twitter   |    Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

J Clin Exp Res. 2015; 3(1): 169-173


Comparison of the efficacy of Clove (Syzygium aromaticum) oil with pioglitazone on dexamethasone induced hepatic steatosis, dyslipidemia and hyperglycemia in albino rats

Chandralekha Netharakere, Nagendra I M Nayak, Vinodraj Kundapur, Nitasha GM Bhat, Paul Mathai, Dasaraju Rajesh, Thotahalli K Chethan, Manisha Ojha.

Abstract
Objective: To evaluate the efficacy of clove oil with pioglitazone on dexamethasone induced hepatic steatosis, dyslipidemia and hyperglycemia in albino rats. Materials and Methods: There were 4 groups of 6 rats each. First group received dexamethasone alone in a dose of 8mg/kg intraperitoneally for 6 days to induce metabolic changes and considered as dexamethasone control. Second group received clove oil orally 6days before dexamethasone and 6 days during dexamethasone administration. Third group received pioglitazone 45mg/kg orally 6 days before dexamethasone and 6 days during dexamethasone administration. Fourth group did not receive any medication and was considered as normal control. Fasting blood sugar, lipid profile, blood sugar 2 hours after glucose load, liver weight, liver volume were recorded and histopathological analysis was done. Results: The effects of clove oil were compared with that of pioglitazone. Dexamethasone caused hepatomegaly, dyslipidemia and hyperglycemia. Both pioglitazone and clove oil significantly reduced hepatomegaly, dyslipidemia and hyperglycemia (P< 0.01). Reduction of blood sugar levels after glucose load was significant with pioglitazone in comparison to clove oil (P< 0.01). Conclusion: Clove oil has comparable efficacy to pioglitazone in dexamethasone induced hepatomegaly, dyslipidemia and fasting hyperglycemia.

Key words: Clove oil, diabetes, glucocorticoid, hepatomegaly, hyperlipoproteinemia, insulin sensitizer


Full text links

Share this Article




ScopeMed Home
Follow ScopeMed on Twitter
Article Tools
Job Opportunities/Service Offers
eJManager OJMS
eJPort Journal Hosting
About ScopeMed
Terms & Conditions
Privacy Policy
Suggest a Journal
Publisher Login
Contact Us

The articles in Scopemed are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Service of eJManager LLC Publishing for Scientific Publications. Copyright © ScopeMedź Information Services.
Scopemed Buttons